Icon

ZAVESCA (nda021348)- (100MG)

MIGLUSTAT ACTELION
100MG
No No
2013-Jun-11 Expired
2010-Jul-31 None
None No
ZAVESCA is a glucosylceramide synthase inhibitor indicated as monotherapy for treatment of adult patients with mild/moderate type 1 Gaucher disease for whom enzyme replacement therapy is not a therapeutic option.
3 0 3
Total Other Developers 3
Drugs with Suitability No
100MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ****** ****** ******** ************** **., ***. *********** **. **, ******* *** ****, ****** ********** ****, ******, ******* ******, ***** (***) ***
****** ************ ******** ******** - ************, *** *********** * ******* **** *** ***, ********, ************ (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.